Sonrotoclax is an antineoplastic.
For research use only. We do not sell to patients.
Name | Sonrotoclax (BGB-11417) |
---|---|
Iupac Chemical Name | N-[4-({[(1r,4r)-4-hydroxy-4-methylcyclohexyl]methyl}amino)-3- nitrobenzene-1-sulfonyl]-4-(2-{(2S)-2-[2-(propan-2-yl)phenyl]pyrrolidin- 1-yl}-7-azaspiro[3.5]nonan-7-yl)-2-[(1H-pyrrolo[2,3-b]pyridin-5- yl)oxy]benzamide |
Synonyms | Sonrotoclax ; BGB-11417 ; BGB11417 ; BGB 11417 |
Molecular Formula | C49H59N7O7S |
Molecular Weight | 890.10 |
Smile | O=C(NS(=O)(C1=CC=C(NC[C@H]2CC[C@](C)(O)CC2)C([N+]([O-])=O)=C1)=O)C3=CC=C(N(CC4)CCC54CC(N6[C@H](C7=CC=CC=C7C(C)C)CCC6)C5)C=C3OC8=CN=C(NC=C9)C9=C8 |
InChiKey | ZQTKOYMWCCSKON-XKXNWSITSA-N |
InChi | InChI=1S/C49H59N7O7S/c1-32(2)39-7-4-5-8-40(39)43-9-6-22-55(43)36-28-49(29-36)19-23-54(24-20-49)35-10-12-41(45(26-35)63-37-25-34-16-21-50-46(34)52-31-37)47(57)53-64(61,62)38-11-13-42(44(27-38)56(59)60)51-30-33-14-17-48(3,58)18-15-33/h4-5,7-8,10-13,16,21,25-27,31-33,36,43,51,58H,6,9,14-15,17-20,22-24,28-30H2,1-3H3,(H,50,52)(H,53,57)/t33-,43-,48-/m0/s1 |
CAS Number | 2383086-06-2 |
Related CAS | 2383086-06-2 |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Solid powder |
---|---|
Purity | ≧98.0% |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
Solubility | Soluble in DMSO |
Handling | |
Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |